Why Ambrx Biopharma Shares Are Trading Higher By Over 550%? Here Are 52 Stocks Moving In Friday’s Mid-Day Session
Gainers
Ambrx Biopharma Inc. (NYSE: AMAM) shares jumped 551.4% to $2.67 after the company announced preliminary Phase 2 results from its ACE-Breast-03 study showing a 57.1% overall response rate.
Earnings Scheduled For November 14, 2022
Companies Reporting Before The Bell
• Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.
12 Health Care Stocks Moving In Wednesday’s After-Market Session
Gainers
ASLAN Pharma (NASDAQ:ASLN) stock moved upwards by 13.7% to $0.54 during Wednesday's after-market session. The market value of their outstanding shares is at $37.6 million.
Tivic Health To Acquire Assets Of Reliefband; Consideration To Be Provided By Tivic Consists Of Up To $33.5M, Of Which Up To $1.5M Can Be Paid, At The Election Of Tivic, In Restricted Common Stock
Company Intends to Dramatically Expand Product Offerings into Bioelectronic Treatment of Nausea
CEO to Host Investor Call/Webcast on Wednesday, October 19th at 1:30 PM PT / 4:30 PM ET
Tivic Health®
Why Nutanix Is Trading Higher By 16%; Here Are 33 Stocks Moving Premarket
Gainers
Bright Green Corporation (NASDAQ: BGXX) shares rose 63.8% to $2.26 in pre-market trading after gaining around 33% on Wednesday.
CORRECTION: Tivic Health Systems Q2 Sales $528.00K Beat $460.00K Estimate
Tivic Health Systems (NASDAQ:TIVC) reported quarterly sales of $528.00 thousand which beat the analyst consensus estimate of $460.00 thousand by 14.78 percent.